ARTICLE | Company News
StemCyte, Rutgers University deal
March 3, 2008 8:00 AM UTC
The university will study StemCyte’s human umbilical cord blood stem cells in conjunction with lithium as a potential treatment for spinal cord injury. StemCyte will receive exclusive commercializatio...